Drug General Information
Drug ID
D05GUK
Former ID
DIB009869
Drug Name
INTOPLICINE
Synonyms
RP-60475; Intoplicine < Rec INN >; 11-[3-(Dimethylamino)propylamino]-8-methyl-7H-benzo[e]pyrido[4,3-b]indol-3-ol
Drug Type
Small molecular drug
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [521454]
Structure
Download
2D MOL

3D MOL

Formula
C21H24N4O
Canonical SMILES
CN(C)CCCNc1ncc(C)c2[nH]c3ccc4cc(O)ccc4c3c12
InChI
1S/C21H24N4O/c1-13-12-23-21(22-9-4-10-25(2)3)19-18-16-7-6-15(26)11-14(16)5-8-17(18)24-20(13)19/h5-8,11-12,24,26H,4,9-10H2,1-3H3,(H,22,23)
InChIKey
QROONAIPJKQFMC-UHFFFAOYSA-N
CAS Number
CAS 125974-72-3
PubChem Compound ID
Target and Pathway
Target(s) Toposisomerase-1 Target Info Modulator
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway DNA replication
Pathway Interaction Database Caspase Cascade in Apoptosis
WikiPathways Integrated Pancreatic Cancer Pathway
References
Ref 521454ClinicalTrials.gov (NCT00003713) Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.